Latest filing published 06 Feb 2026 for Alkermes plc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Richard F. Pops, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Alkermes plc. and Neurocrine Biosciences Inc. We count 18 filings; the first trade dates from 6 May 2021 and the latest from 5 February 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 6 February 2026 came the latest disclosure, a share grant in Alkermes plc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations